Effectiveness of Yunnan Baiyao in Improving Fracture Pain
Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
This will be a randomized, controlled, non-inferiority designed clinical trial. 56 qualified
subjects will be selected and allocated 1:1 to Yunnan Baiyao group and celecoxib group. Each
subject will be treated for 2 weeks and observed for 12 weeks, which will be lasted for 14
weeks during the whole trial. Yunnan Baiyao group will be given 4 times a day, 2 capsules
each time after morning, afternoon and evening meals and before going to bed. One capsule of
Baoxianzi will be provided for the first time to be taken at the same time with Yunnan Baiyao
Capsule, which will be given continuously for 2 weeks. The celecoxib group will be given 1
capsule twice a day after breakfast and dinner for 2 weeks.